Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Stokoe

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Idrugs : the Investigational Drugs Journal|July 5, 2003
Protein phosphorylation drug discovery summit--SRI conference. Targeting kinases and phosphatases for novel therapeutics. 3-5 March 2003, San Diego, CA, USADavid Stokoe
Expert Reviews in Molecular Medicine|June 9, 2005
The phosphoinositide 3-kinase pathway and cancerDavid Stokoe
Angewandte Chemie (International Ed. in English)|March 5, 2014
Selective inhibition of mutant Ras protein through covalent bindingJoachim Rudolph, David Stokoe
BMC Medicine|July 3, 2010
Zinc finger nucleases as tools to understand and treat human diseasesDavid Davis, David Stokoe
EMBO Molecular Medicine|January 6, 2010
Converting cancer mutations into therapeutic opportunitiesTom O'Brien, David Stokoe
Journal of Cell Science|November 23, 2007
New insights into PTENTanja Tamguney, David Stokoe
The Biochemical Journal|January 20, 2005
Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAiBenoit Bilanges, David Stokoe
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2005
Phosphatase and tensin homologue growth suppression without phosphataseDavid Stokoe, Joseph F Costello
Expert Review of Neurotherapeutics|April 18, 2008
PTEN in brain tumorsDaphne Haas-Kogan, David Stokoe
Frontiers in Cell and Developmental Biology|June 8, 2026
Targeting NRF2 addiction in cancer: synthetic lethal strategies beyond direct inhibitionMelat T Gebru, David Stokoe
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Idrugs : the Investigational Drugs Journal|July 5, 2003
Protein phosphorylation drug discovery summit--SRI conference. Targeting kinases and phosphatases for novel therapeutics. 3-5 March 2003, San Diego, CA, USADavid Stokoe
Expert Reviews in Molecular Medicine|June 9, 2005
The phosphoinositide 3-kinase pathway and cancerDavid Stokoe
Angewandte Chemie (International Ed. in English)|March 5, 2014
Selective inhibition of mutant Ras protein through covalent bindingJoachim Rudolph, David Stokoe
BMC Medicine|July 3, 2010
Zinc finger nucleases as tools to understand and treat human diseasesDavid Davis, David Stokoe
EMBO Molecular Medicine|January 6, 2010
Converting cancer mutations into therapeutic opportunitiesTom O'Brien, David Stokoe
Journal of Cell Science|November 23, 2007
New insights into PTENTanja Tamguney, David Stokoe
The Biochemical Journal|January 20, 2005
Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAiBenoit Bilanges, David Stokoe
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2005
Phosphatase and tensin homologue growth suppression without phosphataseDavid Stokoe, Joseph F Costello
Expert Review of Neurotherapeutics|April 18, 2008
PTEN in brain tumorsDaphne Haas-Kogan, David Stokoe
Frontiers in Cell and Developmental Biology|June 8, 2026
Targeting NRF2 addiction in cancer: synthetic lethal strategies beyond direct inhibitionMelat T Gebru, David Stokoe
Pageof 9